Drug allergy in children: what should you know?
Keywords:drug allergy, diagnosis, treatment, children, infants, allergic reactions, dimetindene maleate, Edermik
Drug reactions cause 6.5 % of all hospital admissions. They develop with a rate of 15 % in patients who are treated in hospitals. The risk of drug reactions should be considered in the differential diagnosis when any medical problem occurs in a person who uses medication. In children, the major difficulty in the diagnosis of drug allergy is differentiation of maculopapular drug eruptions from viral exanthem which is observed very commonly in this age group. In treatment of allergic reactions, the first step is to immediately discontinue the drug. Avoidance of using over-the-counter medicines and using drugs orally if possible are important in terms of prevention of drug allergies. Cross-reactivity between drugs with similar structure should be considered when choosing an alternative medication. Antihistamines, in particular dimetindene maleate — Edermik, can be used for the prevention and treatment of drug reactions at the outpatient stage.
Impicciatore P, Choonara I, Clarkson A, Provasi D, Pandolfini C, Bonati M. Incidence of adverse drug reactions in paediatric in/out-patients: a systematic review and meta-analysis of prospective studies. Br J Clin Pharmacol. 2001 Jul;52(1):77-83. doi:10.1046/j.0306-5251.2001.01407.x.
Vyles D, Chiu A, Simpson P, Nimmer M, Adams J, Brousseau DC. Parent-Reported Penicillin Allergy Symptoms in the Pediatric Emergency Department. Acad Pediatr. 2017 Apr;17(3):251-255. doi:10.1016/j.acap.2016.11.004.
Lee SI, Shin MH, Lee HB, et al. Prevalences of symptoms of asthma and other allergic diseases in korean children: a nationwide questionnaire survey. J Korean Med Sci. 2001 Apr;16(2):155-164. doi:10.3346/jkms.2001.16.2.155.
Rebelo Gomes E, Fonseca J, Araujo L, Demoly P. Drug allergy claims in children: from self-reporting to confirmed diagnosis. Clin Exp Allergy. 2008 Jan;38(1):191-198. doi:10.1111/j.1365-2222.2007.02870.x.
Erkoçoğlu M, Kaya A, Civelek E, et al. Prevalence of confirmed immediate type drug hypersensitivity reactions among school children. Pediatr Allergy Immunol. 2013 Mar;24(2):160-167. doi:10.1111/pai.12047.
Esposito S, Castellazzi L, Tagliabue C, Principi N. Allergy to antibiotics in children: an overestimated problem. Int J Antimicrob Agents. 2016 Oct;48(4):361-366. doi:10.1016/j.ijantimicag.2016.08.001.
Doña I, Barrionuevo E, Blanca-Lopez N, et al. Trends in hypersensitivity drug reactions: more drugs, more response patterns, more heterogeneity. J Investig Allergol Clin Immunol. 2014;24(3):143-153; quiz 1 p following 153.
Budnitz DS, Pollock DA, Weidenbach KN, Mendelsohn AB, Schroeder TJ, Annest JL. National surveillance of emergency department visits for outpatient adverse drug events. JAMA. 2006 Oct 18;296(15):1858-1866. doi:10.1001/jama.296.15.1858.
Lange L, Koningsbruggen SV, Rietschel E. Questionnaire-based survey of lifetime-prevalence and character of allergic drug reactions in German children. Pediatr Allergy Immunol. 2008 Nov;19(7):634-638. doi:10.1111/j.1399-3038.2007.00702.x.
Vezir E, Dibek Misirlioglu E, et al. Direct oral provocation tests in non-immediate mild cutaneous reactions related to beta-lactam antibiotics. Pediatr Allergy Immunol. 2016 Feb;27(1):50-54. doi:10.1111/pai.12493.
Gomes ER, Brockow K, Kuyucu S, et al. Drug hypersensitivity in children: report from the pediatric task force of the EAACI Drug Allergy Interest Group. Allergy. 2016 Feb;71(2):149-161. doi:10.1111/all.12774.
Ustinov OV. Drug allergy: specialized care. Available from: https://www.umj.com.ua/article/94307. Accessed: March 21, 2016.
Hubiche T, Milpied B, Cazeau C, Taïeb A, Léauté-Labrèze C. Association of immunologically confirmed delayed drug reaction and human herpesvirus 6 viremia in a pediatric case of drug-induced hypersensitivity syndrome. Dermatology. 2011;222(2):140-141. doi:10.1159/000324506.
Kim B, Kim SZ, Lee J, et al. Clinical profiles of adverse drug reactions spontaneously reported at a single Korean hospital dedicated to children with complex chronic conditions. PLoS One. 2017 Feb 15;12(2):e0172425. doi:10.1371/journal.pone.0172425.
Atanaskovic-Markovic M, Gomes E, Cernadas JR, et al. Diagnosis and management of drug-induced anaphylaxis in children: An EAACI position paper. Pediatr Allergy Immunol. 2019 May;30(3):269-276. doi:10.1111/pai.13034.
Lee SY, Ahn K, Kim J, et al. A Multicenter Retrospective Case Study of Anaphylaxis Triggers by Age in Korean Children. Allergy Asthma Immunol Res. 2016 Nov;8(6):535-540. doi:10.4168/aair.2016.8.6.535.
Motosue MS, Bellolio MF, Van Houten HK, Shah ND, Campbell RL. Increasing Emergency Department Visits for Anaphylaxis, 2005-2014. J Allergy Clin Immunol Pract. 2017 Jan-Feb;5(1):171-175.e3. doi:10.1016/j.jaip.2016.08.013.
Dibek Misirlioglu E, Guvenir H, et al. Severe Cutaneous Adverse Drug Reactions in Pediatric Patients: A Multicenter Study. J Allergy Clin Immunol Pract. 2017 May-Jun;5(3):757-763. doi:10.1016/j.jaip.2017.02.013.
Oh HL, Kang DY, Kang HR, et al. Severe Cutaneous Adverse Reactions in Korean Pediatric Patients: A Study From the Korea SCAR Registry. Allergy Asthma Immunol Res. 2019 Mar;11(2):241-253. doi:10.4168/aair.2019.11.2.241.
Park GM, Park JH, Jung JW, et al. Pediatric adverse drug reactions collected by an electronic reporting system in a single tertiary university hospital. Allergy Asthma Respir Dis. 2016;4(5):354-359. doi:10.4168/AARD.2016.4.5.354.
Kim DW, Choi YC, Lee YS, Nam YH, Jung JA. Analysis of pediatric adverse drug reactions reported to regional pharmacovigilance center of a single university hospital. Allergy Asthma Respir Dis. 2018;6(5):263-269. doi:10.4168/AARD.2018.6.5.263.
Romano A, Caubet JC. Antibiotic allergies in children and adults: from clinical symptoms to skin testing diagnosis. J Allergy Clin Immunol Pract. 2014 Jan-Feb;2(1):3-12. doi:10.1016/j.jaip.2013.11.006.
Trubiano JA, Stone CA, Grayson ML, et al. The 3 Cs of Antibiotic Allergy-Classification, Cross-Reactivity, and Collaboration. J Allergy Clin Immunol Pract. 2017 Nov-Dec;5(6):1532-1542. doi:10.1016/j.jaip.2017.06.017.
Noh SR, Yoon J, Cho HJ, et al. Outcomes of drug provocation tests in Korean children with suspected drug hypersensitivity reaction. Allergy Asthma Respir Dis. 2018;6(1):26-33. doi:10.4168/aard.2018.6.1.26.
Tonson la Tour A, Michelet M, Eigenmann PA, Caubet JC. Natural History of Benign Nonimmediate Allergy to Beta-Lactams in Children: A Prospective Study in Retreated Patients After a Positive and a Negative Provocation Test. J Allergy Clin Immunol Pract. 2018 Jul-Aug;6(4):1321-1326. doi:10.1016/j.jaip.2017.10.008.
Neubert A, Verhamme K, Murray ML, et al. The prescribing of analgesics and non-steroidal anti-inflammatory drugs in paediatric primary care in the UK, Italy and the Netherlands. Pharmacol Res. 2010 Sep;62(3):243-248. doi:10.1016/j.phrs.2010.04.006.
Eustace N, O'Hare B. Use of nonsteroidal anti-inflammatory drugs in infants. A survey of members of the Association of Paediatric Anaesthetists of Great Britain and Ireland. Paediatr Anaesth. 2007 May;17(5):464-469. doi:10.1111/j.1460-9592.2007.02135.x.
Settipane RA, Constantine HP, Settipane GA. Aspirin intolerance and recurrent urticaria in normal adults and children. Epidemiology and review. Allergy. 1980 Mar;35(2):149-154. doi:10.1111/j.1398-9995.1980.tb01730.x.
Doña I, Blanca-López N, Torres MJ, et al. Drug hypersensitivity reactions: response patterns, drug involved, and temporal variations in a large series of patients. J Investig Allergol Clin Immunol. 2012;22(5):363-371.
Guvenir H, Dibek Misirlioglu E, Capanoglu M, et al. The Frequency of Nonsteroidal Anti-Inflammatory Drug Hypersensitivity in Children with Asthma. Int Arch Allergy Immunol. 2018;176(1):26-32. doi:10.1159/000487305.
Liew WK, Chiang WC, Goh AE, et al. Paediatric anaphylaxis in a Singaporean children cohort: changing food allergy triggers over time. Asia Pac Allergy. 2013 Jan;3(1):29-34. doi:10.5415/apallergy.2013.3.1.29.
Gabrielli S, Clarke AE, Eisman H, et al. Disparities in rate, triggers, and management in pediatric and adult cases of suspected drug-induced anaphylaxis in Canada. Immun Inflamm Dis. 2018 Mar;6(1):3-12. doi:10.1002/iid3.201.
Choi J, Lee JY, Kim KH, Choi J, Ahn K, Kim J. Evaluation of drug provocation tests in Korean children: a single center experience. Asian Pac J Allergy Immunol. 2016 Jun;34(2):130-136. doi:10.12932/AP06126.96.36.1996.
Stevenson DD, Sanchez-Borges M, Szczeklik A. Classification of allergic and pseudoallergic reactions to drugs that inhibit cyclooxygenase enzymes. Ann Allergy Asthma Immunol. 2001 Sep;87(3):177-180. doi:10.1016/S1081-1206(10)62221-1.
Kowalski ML, Asero R, Bavbek S, et al. Classification and practical approach to the diagnosis and management of hypersensitivity to nonsteroidal anti-inflammatory drugs. Allergy. 2013 Oct;68(10):1219-12132. doi:10.1111/all.12260.
Kidon M, Blanca-Lopez N, Gomes E, et al. EAACI/ENDA Position Paper: Diagnosis and management of hypersensitivity reactions to non-steroidal anti-inflammatory drugs (NSAIDs) in children and adolescents. Pediatr Allergy Immunol. 2018 Aug;29(5):469-480. doi:10.1111/pai.12915.
Sánchez-Borges M, Capriles-Behrens E, Caballero-Fonseca F. Hypersensitivity to non-steroidal anti-inflammatory drugs in childhood. Pediatr Allergy Immunol. 2004 Aug;15(4):376-380. doi:10.1111/j.1399-3038.2004.00159.x.
Corzo JL, Zambonino MA, Muñoz C, et al. Tolerance to COX-2 inhibitors in children with hypersensitivity to nonsteroidal anti-inflammatory drugs. Br J Dermatol. 2014 Mar;170(3):725-729. doi:10.1111/bjd.12674.
Grohskopf LA, Sokolow LZ, Broder KR, Walter EB, Fry AM, Jernigan DB. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices-United States, 2018-19 Influenza Season. MMWR Recomm Rep. 2018 Aug 24;67(3):1-20. doi:10.15585/mmwr.rr6703a1.
Mayo Clinic. Drug Allergy. Available from: https://www.mayoclinic.org/diseases-conditions/drug-allergy/diagnosis-treatment/drc-20371839. Accessed: October 15, 2020.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our edition uses the copyright terms of Creative Commons for open access journals.
Authors, who are published in this journal, agree with the following terms:
- The authors retain rights for authorship of their article and grant to the edition the right of first publication of the article on a Creative Commons Attribution 4.0 International License, which allows others to freely distribute the published article, with the obligatory reference to the authors of original works and original publication in this journal.
- Directing the article for the publication to the editorial board (publisher), the author agrees with transmitting of rights for the protection and using the article, including parts of the article, which are protected by the copyrights, such as the author’s photo, pictures, charts, tables, etc., including the reproduction in the media and the Internet; for distributing; for the translation of the manuscript in all languages; for export and import of the publications copies of the writers’ article to spread, bringing to the general information.
- The rights mentioned above authors transfer to the edition (publisher) for the unlimited period of validity and on the territory of all countries of the world.
- The authors guarantee that they have exclusive rights for using of the article, which they have sent to the edition (publisher). The edition (the publisher) is not responsible for the violation of given guarantees by the authors to the third parties.
- The authors have the right to conclude separate supplement agreements that relate to non-exclusive distribution of their article in the form in which it had been published in the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.
- The policy of the journal permits and encourages the publication of the article in the Internet (in institutional repository or on a personal website) by the authors, because it contributes to productive scientific discussion and a positive effect on efficiency and dynamics of the citation of the article.
- The rights to the article are deemed transferred by the authors to the edition (the publisher) since the moment of the publication of the article in the printed or electronic version of journal.